PD
TYRA icon

Point72 (DIFC)’s Tyra Biosciences TYRA Stock Holding History

Point72 (DIFC)’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,330
Closed -$22.3K – 1876
2025
Q2 		$22.3K Buy
2,330
+57
+3% +$542 ﹤0.01% 1218
2025
Q1 		$21.1K Buy
2,273
+1,712
+305% +$22.2K ﹤0.01% 1344
2024
Q4 		$7.79K Buy
+561
New +$10.2K ﹤0.01% 1358

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
APMC
Alta Partners Management Company Jackson, Wyoming $151M AUM 296.21% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
CPX
Canaan Partners XI Menlo Park, California $76.1M AUM 638.59% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Point72 (DIFC)'s TYRA Position: Q3 2025 in Review

Point72 (DIFC) sold out of Tyra Biosciences (TYRA) in Q3 2025, closing a stake of 2,330 shares — an estimated $22.3K sold.

Point72 (DIFC) first reported a position in TYRA in Q4 2024 and held it in 3 quarters. The position peaked at $22.3K in Q2 2025. 116 funds tracked by Wall St. Rank hold TYRA as of Q3 2025.

  • Point72 (DIFC) reported no remaining Tyra Biosciences position as of Q3 2025 after selling out during the quarter.
  • Point72 (DIFC) sold 2,330 Tyra Biosciences shares in Q3 2025, an estimated $22.3K.
  • Point72 (DIFC) first reported a position in Tyra Biosciences in Q4 2024 and held it in 3 quarters.
  • Point72 (DIFC)'s Tyra Biosciences position peaked at $22.3K in Q2 2025.
  • 116 funds tracked by Wall St. Rank held Tyra Biosciences as of Q3 2025.

Based on Point72 (DIFC)'s 13F filing for Q3 2025, filed 14 Nov 2025.